New Anticoagulation Control for Toyobo-LVAS Using the CoaguChek XS^® / 日本心臓血管外科学会雑誌

Aggressive anticoagulation therapy is necessary when Toyobo-LVAS is used for long-term treatment of severe heart failure. However, it is necessary to regulate it carefully if there is a hemorrhagic complication due to thromboembolism, but repeated blood testing is painful. We compared simple measurement with the CoaguChek XS^® with the conventional blood testing method. The correlation coefficient was 0.916, and the regression line was <i>Y</i>=0.8027<i>X</i>+0.3399. In addition, drawing blood using the CoaguChek XS^® was very effective in the reported pain reduction in patients.